Aptevo Therapeutics Inc Share Price

NASDAQ: APVO

Small Cap

$1.50

+0.06

(+3.82%)

as on September 17, 2025 at 1:29 am IST

$₹

Aptevo Therapeutics Inc Stock Performance

as on September 17, 2025 at 1:29 am IST

Day's Low
Day's High
$1.42
Day's Price Range
$2.71
$1.5
5.33%
Downside
80.67%
Upside
52 Week's Low
52 Week's High
$1.4
52-Week Price Range
$381.1
$1.5
6.67%
Downside
25306.67%
Upside

Aptevo Therapeutics Inc share price movements today

Previous Close: $1.44
Open: $2.19
Volume: 101.8M
Day's Low - High: $1.42 - $2.71
52 Week Low - High: $1.4 - $381.1

Aptevo Therapeutics Inc Historical Returns

1 Month Return: -28 %
3 Month Return: -60.66 %
1 Year Return: -99.41 %
3 Year Return: -100 %
5 Year Return: -100 %

Aptevo Therapeutics Inc Stock Fundamentals & Key Indicators

Check Aptevo Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$4.8M

EPS (TTM)

-316.8

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

Industry PE ratio

P/B Ratio

0.0005

PEG Ratio

EBITDA

-24.0M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-437.34%

Aptevo Therapeutics Inc Stock Valuation

Track how Aptevo Therapeutics Inc P/E has moved over time to understand its valuation trends.

Aptevo Therapeutics Inc in the last 5 years

Overview
Trends

Lowest (0.00x)

September 16, 2025

Industry (0.00x)

September 16, 2025

Today (0.00x)

September 16, 2025

Highest (0.00x)

September 16, 2025

LowHigh

Today’s Price to Earnings Ratio: 0.00x

Aptevo Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Aptevo Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Aptevo Therapeutics Inc	BUY	$4.8M	-100%	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$61.1B	251.26%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$101.2B	47.46%	28.09	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$59.6B	0.6%	14.1	31.37%

Stock Returns calculator for Aptevo Therapeutics Inc Stock including INR - Dollar returns

The Aptevo Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Aptevo Therapeutics Inc investment value today

Current value as on today

₹5,482

Returns

₹94,518

(-94.52%)

Returns from Aptevo Therapeutics Inc Stock

₹99,386 (-99.39%)

Dollar Returns*

₹4,867 (+4.87%)

Analyst Recommendation on Aptevo Therapeutics Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Aptevo Therapeutics Inc. Average target price of $420

Aptevo Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Aptevo Therapeutics Inc.

What analysts predicted

99.64%UPSIDE

Target Price

$420

Current Price

$1.5

Analyzed by

8 Analysts

Target

$420.00

Aptevo Therapeutics Inc target price $420, a slight upside of 99.64% compared to current price of $1.5. According to 8 analysts rating.

Aptevo Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Aptevo Therapeutics Inc Stock has increased by 66% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 18, 2025 to September 17, 2025

Change:66% versus previous 30 day period

Aptevo Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	0	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-7	-8	-6	-6	-6	-6	-5	-6	-6	-6
EBITDA	-7	-8	-6	-6	-6	-5	-5	-6	-6	-6
Interest Expense	9	-	-	9	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	1	-7	-6	-6	-6	-5	-5	-6	-6	-6
Income Tax Expense	-9	0	0	0	0	0	-	-	-	-
Net Income	11	-7	-6	-5	-6	-5	-5	-6	-6	-6
Net Profit Margin	0.00%	0.00%	0.00%	-654.43%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Aptevo Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	33	36	14	23	32	4	12	3	-	-
Gross Profit	16	12	9	11	12	-13	12	-14	0	0
Operating Income	-61	-126	-53	-51	-40	-27	-21	-28	-28	-24
EBITDA	-58	-64	-48	-49	-39	-26	-20	-27	-28	-23
Interest Expense	-	-	-	-	-	-	7	35	-	-
Depreciation	-	-	3	2	2	1	1	0	0	0
Income Before Tax	-61	-127	-55	-53	-43	-30	-29	7	-18	-24
Income Tax Expense	-2	-15	-23	-23	-2	-12	-2	-35	-1	-
Net Income	-59	-112	6	-53	-40	-18	-27	8	-17	-24
Net Profit Margin	-176.53%	-308.54%	47.57%	-232.75%	-124.75%	-428.13%	-222.20%	257.77%	0.00%	0.00%

Aptevo Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-7	-6	-6	-6	-5	-5	-6	-6	-6
Operating Cash Flow	-4	-6	-5	-6	-6	-5	-5	-6	-7
Investing Cash Flow	-	-	-	-	-	-	-	-	-
Financing Cash Flow	0	4	3	0	3	4	6	-	14
Change in Cash	-4	-1	-2	-6	-2	0	0	-6	7

Aptevo Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	-112	6	-53	-40	-17	-28	8	-17	-24
Operating Cash Flow	-36	-41	-51	-42	-29	-21	-21	-11	-23
Investing Cash Flow	-47	29	72	4	28	0	0	-	-
Financing Cash Flow	89	9	0	20	23	26	-2	5	15
Change in Cash	5	-2	20	-18	22	3	-23	-5	-8

Global Institutional Holdings in Aptevo Therapeutics Inc

Funds	Holdings
Geode Capital Management, LLC	0.02%
Tower Research Capital LLC	0.01%
CLEAR STREET LLC.	0%
Bank of America Corp	0%
SBI Securities Co Ltd	0%

See all

Insights on Aptevo Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.2% return, outperforming this stock by 167.2%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 211.5%
NEGATIVE IMPACT
Price Dip
In the last 1 month, APVO stock has moved down by -28.0%

About Aptevo Therapeutics Inc

aptevo therapeutics is a biotech company primarily focused on bringing novel oncology and hematology therapeutics to market. we leverage the innovative adaptir™ platform technology, a unique approach to cancer immunotherapy, to improve outcomes for cancer patients. based in seattle, washington, the company is proud of its empowering work environment, entrepreneurial culture, and proprietary platform technology. as a result, aptevo has been able to attract some of the most innovative minds in the field. many of our team members have notable experience with other pioneering biotech companies including trubion, zymogenetics, immunex, dendreon, and vlst. at aptevo therapeutics, our core values of ownership and collaboration—combined with a history of innovation, dedication, and development—are positioning aptevo therapeutics to develop the science of what’s next in biotechnology.

Organisation	Aptevo Therapeutics Inc
Headquarters	2401 4th Avenue, Seattle, WA, United States, 98121
Industry	Health Technology
CEO	Mr. Marvin L. White
E-voting on shares	Click here to vote

Key Management of Aptevo Therapeutics Inc

Name	Title
Mr. Marvin L. White	President, CEO & Director
Mr. Jeffrey G. Lamothe CA	Executive VP & COO
Ms. SoYoung Kwon J.D., LL.M.	Corporate Secretary, Senior VP, General Counsel, Business Development & Corporate Affairs
Ms. Daphne L. Taylor CPA	Senior VP & CFO
Dr. Dirk Huebner M.D.	Chief Medical Officer

FAQs

What is Aptevo Therapeutics Inc share price today?

Aptevo Therapeutics Inc share price today is $1.5 as on September 17, 2025 at 1:29 am IST at the close of the market. Aptevo Therapeutics Inc share today touched a day high of $2.71 and a low of $1.42.

What is the 52 week high and 52 week low for Aptevo Therapeutics Inc share?

Aptevo Therapeutics Inc share touched a 52 week high of $381.1 on October 22, 2024 and a 52 week low of $1.4 on September 15, 2025. Aptevo Therapeutics Inc stock price today i.e. September 17, 2025 at 1:29 am IST is closed at $1.5,which is 99.61% down from its 52 week high and 7.14% up from its 52 week low.

What is Aptevo Therapeutics Inc's market capitalisation today?

Aptevo Therapeutics Inc market capitalisation is $0.00T as on September 17, 2025 at 1:29 am IST.

How to invest in Aptevo Therapeutics Inc Stock (APVO) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Aptevo Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Aptevo Therapeutics Inc Shares that will get you 1.0000 shares as per Aptevo Therapeutics Inc share price of $1.5 per share as on September 17, 2025 at 1:29 am IST.

What is the minimum amount required to buy Aptevo Therapeutics Inc Stock (APVO) from India?

Indian investors can start investing in Aptevo Therapeutics Inc (APVO) shares with as little as ₹88.042 or $1 (as of September 17, 2025 at 12:45 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹880.42 in Aptevo Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 17, 2025 at 12:45 pm IST). Based on Aptevo Therapeutics Inc share’s latest price of $1.5 as on September 17, 2025 at 1:29 am IST, you will get 6.6667 shares of Aptevo Therapeutics Inc. Learn more about fractional shares .

What are the returns that Aptevo Therapeutics Inc has given to Indian investors in the last 5 years?

Aptevo Therapeutics Inc stock has given -100% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?